Economic information and modeling reportBudget impact model
Perspective and time frame
3 evidence topics · 7 sources
Budget impact model of lirafugratinib: perspective and time frame
No evidence found.
Previously treated FGFR2 fusion or rearrangement-positive cholangiocarcinoma
Economic information and modeling reportBudget impact model
3 evidence topics · 7 sources
No evidence found.